IL-6 Inhibitors Market - Global Outlook and Forecast 2021-2027

April 2021 | 94 pages | ID: IB482FF8F3B2EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of IL-6 Inhibitors in Global, including the following market information:

Global IL-6 Inhibitors Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global IL-6 Inhibitors market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the IL-6 Inhibitors companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global IL-6 Inhibitors Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global IL-6 Inhibitors Market Segment Percentages, By Type, 2020 (%)

• IL-6 Receptors Antagonistic Anitibody
• Antibody against IL-6

China IL-6 Inhibitors Market, By Application, 2016-2021, 2022-2027 ($ millions)

China IL-6 Inhibitors Market Segment Percentages, By Application, 2020 (%)

• Autoimmune Diease Treatment
• Ajuvant Cancer Treatment
• COVID-19 Therapy

Global IL-6 Inhibitors Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global IL-6 Inhibitors Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total IL-6 Inhibitors Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total IL-6 Inhibitors Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Roche
• Regeneron Pharmaceuticals Inc.
• Sanofi
• Janssen Global Services LLC
• Novimmune SA
• UCB Pharma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 IL-6 Inhibitors Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global IL-6 Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL IL-6 INHIBITORS OVERALL MARKET SIZE

2.1 Global IL-6 Inhibitors Market Size: 2021 VS 2027
2.2 Global IL-6 Inhibitors Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top IL-6 Inhibitors Players in Global Market
3.2 Top Global IL-6 Inhibitors Companies Ranked by Revenue
3.3 Global IL-6 Inhibitors Revenue by Companies
3.4 Top 3 and Top 5 IL-6 Inhibitors Companies in Global Market, by Revenue in 2020
3.5 Global Companies IL-6 Inhibitors Product Type
3.6 Tier 1, Tier 2 and Tier 3 IL-6 Inhibitors Players in Global Market
  3.6.1 List of Global Tier 1 IL-6 Inhibitors Companies
  3.6.2 List of Global Tier 2 and Tier 3 IL-6 Inhibitors Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global IL-6 Inhibitors Market Size Markets, 2021 & 2027
  4.1.2 IL-6 Receptors Antagonistic Anitibody
  4.1.3 Antibody against IL-6
4.2 By Type - Global IL-6 Inhibitors Revenue & Forecasts
  4.2.1 By Type - Global IL-6 Inhibitors Revenue, 2016-2021
  4.2.2 By Type - Global IL-6 Inhibitors Revenue, 2022-2027
  4.2.3 By Type - Global IL-6 Inhibitors Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global IL-6 Inhibitors Market Size, 2021 & 2027
  5.1.2 Autoimmune Diease Treatment
  5.1.3 Ajuvant Cancer Treatment
  5.1.4 COVID-19 Therapy
5.2 By Application - Global IL-6 Inhibitors Revenue & Forecasts
  5.2.1 By Application - Global IL-6 Inhibitors Revenue, 2016-2021
  5.2.2 By Application - Global IL-6 Inhibitors Revenue, 2022-2027
  5.2.3 By Application - Global IL-6 Inhibitors Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global IL-6 Inhibitors Market Size, 2021 & 2027
6.2 By Region - Global IL-6 Inhibitors Revenue & Forecasts
  6.2.1 By Region - Global IL-6 Inhibitors Revenue, 2016-2021
  6.2.2 By Region - Global IL-6 Inhibitors Revenue, 2022-2027
  6.2.3 By Region - Global IL-6 Inhibitors Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America IL-6 Inhibitors Revenue, 2016-2027
  6.3.2 US IL-6 Inhibitors Market Size, 2016-2027
  6.3.3 Canada IL-6 Inhibitors Market Size, 2016-2027
  6.3.4 Mexico IL-6 Inhibitors Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe IL-6 Inhibitors Revenue, 2016-2027
  6.4.2 Germany IL-6 Inhibitors Market Size, 2016-2027
  6.4.3 France IL-6 Inhibitors Market Size, 2016-2027
  6.4.4 U.K. IL-6 Inhibitors Market Size, 2016-2027
  6.4.5 Italy IL-6 Inhibitors Market Size, 2016-2027
  6.4.6 Russia IL-6 Inhibitors Market Size, 2016-2027
  6.4.7 Nordic Countries IL-6 Inhibitors Market Size, 2016-2027
  6.4.8 Benelux IL-6 Inhibitors Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia IL-6 Inhibitors Revenue, 2016-2027
  6.5.2 China IL-6 Inhibitors Market Size, 2016-2027
  6.5.3 Japan IL-6 Inhibitors Market Size, 2016-2027
  6.5.4 South Korea IL-6 Inhibitors Market Size, 2016-2027
  6.5.5 Southeast Asia IL-6 Inhibitors Market Size, 2016-2027
  6.5.6 India IL-6 Inhibitors Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America IL-6 Inhibitors Revenue, 2016-2027
  6.6.2 Brazil IL-6 Inhibitors Market Size, 2016-2027
  6.6.3 Argentina IL-6 Inhibitors Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa IL-6 Inhibitors Revenue, 2016-2027
  6.7.2 Turkey IL-6 Inhibitors Market Size, 2016-2027
  6.7.3 Israel IL-6 Inhibitors Market Size, 2016-2027
  6.7.4 Saudi Arabia IL-6 Inhibitors Market Size, 2016-2027
  6.7.5 UAE IL-6 Inhibitors Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche IL-6 Inhibitors Major Product Offerings
  7.1.4 Roche IL-6 Inhibitors Revenue in Global (2016-2021)
  7.1.5 Roche Key News
7.2 Regeneron Pharmaceuticals Inc.
  7.2.1 Regeneron Pharmaceuticals Inc. Corporate Summary
  7.2.2 Regeneron Pharmaceuticals Inc. Business Overview
  7.2.3 Regeneron Pharmaceuticals Inc. IL-6 Inhibitors Major Product Offerings
  7.2.4 Regeneron Pharmaceuticals Inc. IL-6 Inhibitors Revenue in Global (2016-2021)
  7.2.5 Regeneron Pharmaceuticals Inc. Key News
7.3 Sanofi
  7.3.1 Sanofi Corporate Summary
  7.3.2 Sanofi Business Overview
  7.3.3 Sanofi IL-6 Inhibitors Major Product Offerings
  7.3.4 Sanofi IL-6 Inhibitors Revenue in Global (2016-2021)
  7.3.5 Sanofi Key News
7.4 Janssen Global Services LLC
  7.4.1 Janssen Global Services LLC Corporate Summary
  7.4.2 Janssen Global Services LLC Business Overview
  7.4.3 Janssen Global Services LLC IL-6 Inhibitors Major Product Offerings
  7.4.4 Janssen Global Services LLC IL-6 Inhibitors Revenue in Global (2016-2021)
  7.4.5 Janssen Global Services LLC Key News
7.5 Novimmune SA
  7.5.1 Novimmune SA Corporate Summary
  7.5.2 Novimmune SA Business Overview
  7.5.3 Novimmune SA IL-6 Inhibitors Major Product Offerings
  7.5.4 Novimmune SA IL-6 Inhibitors Revenue in Global (2016-2021)
  7.5.5 Novimmune SA Key News
7.6 UCB Pharma
  7.6.1 UCB Pharma Corporate Summary
  7.6.2 UCB Pharma Business Overview
  7.6.3 UCB Pharma IL-6 Inhibitors Major Product Offerings
  7.6.4 UCB Pharma IL-6 Inhibitors Revenue in Global (2016-2021)
  7.6.5 UCB Pharma Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. IL-6 Inhibitors Market Opportunities & Trends in Global Market
Table 2. IL-6 Inhibitors Market Drivers in Global Market
Table 3. IL-6 Inhibitors Market Restraints in Global Market
Table 4. Key Players of IL-6 Inhibitors in Global Market
Table 5. Top IL-6 Inhibitors Players in Global Market, Ranking by Revenue (2019)
Table 6. Global IL-6 Inhibitors Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global IL-6 Inhibitors Revenue Share by Companies, 2016-2021
Table 8. Global Companies IL-6 Inhibitors Product Type
Table 9. List of Global Tier 1 IL-6 Inhibitors Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 IL-6 Inhibitors Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global IL-6 Inhibitors Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - IL-6 Inhibitors Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - IL-6 Inhibitors Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global IL-6 Inhibitors Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - IL-6 Inhibitors Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - IL-6 Inhibitors Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global IL-6 Inhibitors Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global IL-6 Inhibitors Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global IL-6 Inhibitors Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America IL-6 Inhibitors Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America IL-6 Inhibitors Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe IL-6 Inhibitors Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe IL-6 Inhibitors Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia IL-6 Inhibitors Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia IL-6 Inhibitors Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America IL-6 Inhibitors Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America IL-6 Inhibitors Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa IL-6 Inhibitors Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa IL-6 Inhibitors Revenue, (US$, Mn), 2022-2027
Table 30. Roche Corporate Summary
Table 31. Roche IL-6 Inhibitors Product Offerings
Table 32. Roche IL-6 Inhibitors Revenue (US$, Mn), (2016-2021)
Table 33. Regeneron Pharmaceuticals Inc. Corporate Summary
Table 34. Regeneron Pharmaceuticals Inc. IL-6 Inhibitors Product Offerings
Table 35. Regeneron Pharmaceuticals Inc. IL-6 Inhibitors Revenue (US$, Mn), (2016-2021)
Table 36. Sanofi Corporate Summary
Table 37. Sanofi IL-6 Inhibitors Product Offerings
Table 38. Sanofi IL-6 Inhibitors Revenue (US$, Mn), (2016-2021)
Table 39. Janssen Global Services LLC Corporate Summary
Table 40. Janssen Global Services LLC IL-6 Inhibitors Product Offerings
Table 41. Janssen Global Services LLC IL-6 Inhibitors Revenue (US$, Mn), (2016-2021)
Table 42. Novimmune SA Corporate Summary
Table 43. Novimmune SA IL-6 Inhibitors Product Offerings
Table 44. Novimmune SA IL-6 Inhibitors Revenue (US$, Mn), (2016-2021)
Table 45. UCB Pharma Corporate Summary
Table 46. UCB Pharma IL-6 Inhibitors Product Offerings
Table 47. UCB Pharma IL-6 Inhibitors Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. IL-6 Inhibitors Segment by Type
Figure 2. IL-6 Inhibitors Segment by Application
Figure 3. Global IL-6 Inhibitors Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global IL-6 Inhibitors Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global IL-6 Inhibitors Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by IL-6 Inhibitors Revenue in 2020
Figure 8. By Type - Global IL-6 Inhibitors Revenue Market Share, 2016-2027
Figure 9. By Application - Global IL-6 Inhibitors Revenue Market Share, 2016-2027
Figure 10. By Region - Global IL-6 Inhibitors Revenue Market Share, 2016-2027
Figure 11. By Country - North America IL-6 Inhibitors Revenue Market Share, 2016-2027
Figure 12. US IL-6 Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 13. Canada IL-6 Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico IL-6 Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe IL-6 Inhibitors Revenue Market Share, 2016-2027
Figure 16. Germany IL-6 Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 17. France IL-6 Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. IL-6 Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 19. Italy IL-6 Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 20. Russia IL-6 Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries IL-6 Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux IL-6 Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia IL-6 Inhibitors Revenue Market Share, 2016-2027
Figure 24. China IL-6 Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 25. Japan IL-6 Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea IL-6 Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia IL-6 Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 28. India IL-6 Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America IL-6 Inhibitors Revenue Market Share, 2016-2027
Figure 30. Brazil IL-6 Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina IL-6 Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa IL-6 Inhibitors Revenue Market Share, 2016-2027
Figure 33. Turkey IL-6 Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 34. Israel IL-6 Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia IL-6 Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 36. UAE IL-6 Inhibitors Revenue, (US$, Mn), 2016-2027
Figure 37. Roche IL-6 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Regeneron Pharmaceuticals Inc. IL-6 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Sanofi IL-6 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Janssen Global Services LLC IL-6 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Novimmune SA IL-6 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2016-2021)